Novo Nordisk A/S Sponsored ADR logo

Novo Nordisk A/S Sponsored ADR (NVO)

Market Closed
27 Feb, 20:00
NYSE NYSE
$
37. 45
-0.17
-0.45%
$
210.86B Market Cap
48.26 P/E Ratio
0.56% Div Yield
24,007,597 Volume
0 Eps
$ 37.62
Previous Close
Day Range
37.33 37.86
Year Range
37.31 91.9
Want to track NVO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NVO earnings report is expected in 65 days (6 May 2026)
Is Novo Nordisk Stock a Millionaire Maker?

Is Novo Nordisk Stock a Millionaire Maker?

Novo Nordisk's already strong financials could look even better in the future as the company's drugs have loads of potential. The company's high-profit margins make it likely that earnings will soar right along with sales.

Fool | 1 year ago
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.

Zacks | 1 year ago